Sunday, March 9, 2025
54 F
New York

The peer review system is broken. We asked academics how to fix it

The peer review process is a cornerstone of modern scholarship. Before new work is published in an academic journal, experts scrutinise the evidence, research and arguments to make sure they stack up.

However, many authors, reviewers and editors have problems with the way the modern peer review system works. It can be slow, opaque and cliquey, and it runs on volunteer labour from already overworked academics.

Last month, one of us (Kelly-Ann Allen) expressed her frustration at the difficulties of finding peer reviewers on Twitter. Hundreds of replies later, we had a huge crowd-sourced collection of criticisms of peer review and suggestions for how to make it better.

The suggestions for journals, publishers and universities show there is plenty to be done to make peer review more accountable, fair and inclusive. We have summarised our full findings below.

Three challenges of peer review

We see three main challenges facing the peer review system.

First, peer review can be exploitative.

Many of the companies that publish academic journals make a profit from subscriptions and sales. However, the authors, editors and peer reviewers generally give their time and effort on a voluntary basis, effectively performing free labour.

And while peer review is often seen as a collective enterprise of the academic community, in practice a small fraction of researchers do most of the work. One study of biomedical journals found that, in 2015, just 20% of researchers performed up to 94% of the peer reviewing.

Peer review can be a ‘black box’

The second challenge is a lack of transparency in the peer review process.

Peer review is generally carried out anonymously: researchers don’t know who is reviewing their work, and reviewers don’t know whose work they are reviewing. This provides space for honesty, but can also make the process less open and accountable.

The opacity may also suppress discussion, protect biases, and decrease the quality of the reviews.

Peer review can be slow

The final challenge is the speed of peer review.

When a researcher submits a paper to a journal, if they make it past initial rejection, they may face a long wait for review and eventual publication. It is not uncommon for research to be published a year or more after submission.

This delay is bad for everyone. For policymakers, leaders and the public, it means they may be making decisions based on outdated scientific evidence. For scholars, delays can stall their careers as they wait for the publications they need to get promotions or tenure.

Scholars suggest the delays are typically caused by a shortage of reviewers. Many academics report challenging workloads can discourage them from participating in peer review, and this has become worse since the onset of the COVID-19 pandemic.

It has also been found that many journals rely heavily on US and European reviewers, limiting the size and diversity of the pool of reviewers.

Can we fix peer review?

So, what can be done? Most of the constructive suggestions from the large Twitter conversation mentioned earlier fell into three categories.

First, many suggested there should be better incentives for conducting peer reviews.

This might include publishers paying reviewers (the journals of the American Economic Association already do this) or giving some profits to research departments. Journals could also offer reviewers free subscriptions, publication fee vouchers, or fast-track reviews.

However, we should recognise that journals offering incentives might create new problems.

Another suggestion is that universities could do better in acknowledging peer review as part of the academic workload, and perhaps reward outstanding contributors to peer review.

Some Twitter commentators argued tenured scholars should review a certain number of articles each year. Others thought more should be done to support non-profit journals, given a recent study found some 140 journals in Australia alone ceased publishing between 2011 and 2021.

Most respondents agreed that conflicts of interest should be avoided. Some suggested databases of experts would make it easier to find relevant reviewers.

Use more inclusive peer review recruitment strategies

Many respondents also suggested journals can improve how they recruit reviewers, and what work they distribute. Expert reviewers could be selected on the basis of method or content expertise, and asked to focus on that element rather than both.

Respondents also argued journals should do more to tailor their invitations to target the most relevant experts, with a simpler process to accept or reject the offer.

Others felt that more non-tenured scholars, PhD researchers, people working in related industries, and retired experts should be recruited. More peer review training for graduate students and increased representation for women and underrepresented minorities would be a good start.

Rethink double-blind peer review

Some repondents pointed to a growing movement towards more open peer review processes, which may create a more human and transparent approach to reviewing. For example, Royal Society Open Science publishes all decisions, review letters, and voluntary identification of peer reviewers.

Another suggestion to speed up the publishing process was to give higher priority to time-sensitive research.

What can be done?

The overall message from the enormous response to a single tweet is that there is a need for systemic changes within the peer review process.

There is no shortage of ideas for how to improve the process for the benefit of scholars and the broader public. However, it will be up to journals, publishers and universities to put them into practice and create a more accountable, fair and inclusive system.

Hot this week

Latest Pharma & Biotech News: Breakthroughs in Treatments and Emerging Therapies

The pharmaceutical and biotechnology industries are at the forefront of scientific progress, continually advancing treatments and therapies to address an array of health conditions. With groundbreaking innovations and regulatory approvals shaping the market, keeping up with pharma news and biotech news is crucial for healthcare professionals, researchers, and investors alike. The latest developments in drug discovery, gene therapies, personalized medicine, and cutting-edge biopharmaceuticals are transforming the landscape of modern medicine. Understanding the current state of the pharma industry as operating businesses news analysis reveals the dynamic interplay between innovation, market forces, and patient care. This article explores the most recent breakthroughs in treatments, major pharmaceutical sector news, and the impact of emerging therapies on global healthcare.

A New Drug Stronger Than Fentanyl: Potential Risks, Benefits, and Medical Implications

In recent years, the opioid crisis has reached unprecedented levels, with fentanyl emerging as one of the deadliest drugs contributing to overdose-related fatalities. Now, a new drug stronger than fentanyl has entered the conversation, raising concerns among healthcare professionals, policymakers, and law enforcement agencies. As scientists and pharmaceutical companies continue to develop novel opioids for medical use, the potential risks and benefits of these powerful substances must be thoroughly examined. Understanding the implications of these new compounds is essential for balancing pain management needs with the ongoing fight against opioid misuse and addiction. Opioid analgesics have long been used to treat severe pain, particularly in cases of terminal illness, post-surgical recovery, and chronic pain conditions. However, the emergence of synthetic opioids that surpass the potency of fentanyl presents new challenges in both medicine and public health. These novel substances, which are sometimes referred to as "nieuwe drugs" in international discussions, demand careful scrutiny. Their introduction into clinical practice or illicit markets could have profound effects on overdose rates, addiction treatment approaches, and regulatory policies. This article explores the medical applications, risks, and ethical considerations associated with a new drug stronger than fentanyl, offering a comprehensive analysis for healthcare professionals and policymakers.

Breakthroughs in Depression Treatment: Exploring the Latest New Depression Medication Options

Depression remains one of the most pressing mental health challenges worldwide, affecting millions of individuals and profoundly impacting their quality of life. Over the years, significant strides have been made in understanding the neurobiological mechanisms underlying depression, leading to the development of innovative pharmacological treatments. The emergence of new depression medication has transformed treatment options, offering hope to individuals who have not responded well to traditional antidepressants. As researchers continue to explore novel mechanisms and refine therapeutic approaches, new drugs for depression are poised to revolutionize mental health care. This article delves into the latest advancements in depression treatment, examining how new depression meds are reshaping the landscape of pharmacological therapy and highlighting promising breakthroughs in drug development.

Breakthroughs in Cancer Treatment: Exploring the Potential of a New Cancer Medication

Cancer remains one of the most formidable challenges in modern medicine, affecting millions of lives globally. Despite advances in early detection, treatment, and supportive care, many forms of cancer remain resistant to conventional therapies, necessitating continuous research into novel approaches. The emergence of a new cancer medication can dramatically alter the treatment landscape, offering fresh hope to patients who have exhausted existing options. In recent years, innovative cancer drugs have targeted tumor biology with greater precision, leveraging mechanisms such as immunotherapy, targeted therapy, and personalized medicine. As researchers push the boundaries of medical science, the development of a new cancer drug has the potential to redefine treatment protocols, improve survival rates, and enhance the quality of life for patients battling this disease. The rapid evolution of oncology treatments underscores the importance of understanding how new cancer drugs work, their mechanisms of action, and their impact on patient outcomes. This article explores the latest breakthroughs in cancer treatment, delves into the science behind emerging medications, and assesses their potential in reshaping the future of cancer care. By examining the clinical research, real-world applications, and regulatory considerations, we provide a comprehensive analysis of how these advancements can influence both current and future cancer therapies.

Best Leukemia Meds: Understanding Treatment Options and Their Effectiveness

Leukemia is a complex and multifaceted malignancy that affects blood-forming tissues, primarily the bone marrow and lymphatic system. It encompasses a variety of subtypes, each with distinct pathological mechanisms and treatment approaches. Over the years, advancements in pharmacology have significantly improved survival rates and quality of life for leukemia patients. The development of targeted leukemia drugs and innovative treatment strategies has revolutionized the management of the disease. This article explores the best leukemia meds available today, analyzing their effectiveness, mechanisms of action, and potential side effects to provide a comprehensive resource for patients, caregivers, and healthcare professionals.

Topics

Latest Pharma & Biotech News: Breakthroughs in Treatments and Emerging Therapies

The pharmaceutical and biotechnology industries are at the forefront of scientific progress, continually advancing treatments and therapies to address an array of health conditions. With groundbreaking innovations and regulatory approvals shaping the market, keeping up with pharma news and biotech news is crucial for healthcare professionals, researchers, and investors alike. The latest developments in drug discovery, gene therapies, personalized medicine, and cutting-edge biopharmaceuticals are transforming the landscape of modern medicine. Understanding the current state of the pharma industry as operating businesses news analysis reveals the dynamic interplay between innovation, market forces, and patient care. This article explores the most recent breakthroughs in treatments, major pharmaceutical sector news, and the impact of emerging therapies on global healthcare.

A New Drug Stronger Than Fentanyl: Potential Risks, Benefits, and Medical Implications

In recent years, the opioid crisis has reached unprecedented levels, with fentanyl emerging as one of the deadliest drugs contributing to overdose-related fatalities. Now, a new drug stronger than fentanyl has entered the conversation, raising concerns among healthcare professionals, policymakers, and law enforcement agencies. As scientists and pharmaceutical companies continue to develop novel opioids for medical use, the potential risks and benefits of these powerful substances must be thoroughly examined. Understanding the implications of these new compounds is essential for balancing pain management needs with the ongoing fight against opioid misuse and addiction. Opioid analgesics have long been used to treat severe pain, particularly in cases of terminal illness, post-surgical recovery, and chronic pain conditions. However, the emergence of synthetic opioids that surpass the potency of fentanyl presents new challenges in both medicine and public health. These novel substances, which are sometimes referred to as "nieuwe drugs" in international discussions, demand careful scrutiny. Their introduction into clinical practice or illicit markets could have profound effects on overdose rates, addiction treatment approaches, and regulatory policies. This article explores the medical applications, risks, and ethical considerations associated with a new drug stronger than fentanyl, offering a comprehensive analysis for healthcare professionals and policymakers.

Breakthroughs in Depression Treatment: Exploring the Latest New Depression Medication Options

Depression remains one of the most pressing mental health challenges worldwide, affecting millions of individuals and profoundly impacting their quality of life. Over the years, significant strides have been made in understanding the neurobiological mechanisms underlying depression, leading to the development of innovative pharmacological treatments. The emergence of new depression medication has transformed treatment options, offering hope to individuals who have not responded well to traditional antidepressants. As researchers continue to explore novel mechanisms and refine therapeutic approaches, new drugs for depression are poised to revolutionize mental health care. This article delves into the latest advancements in depression treatment, examining how new depression meds are reshaping the landscape of pharmacological therapy and highlighting promising breakthroughs in drug development.

Breakthroughs in Cancer Treatment: Exploring the Potential of a New Cancer Medication

Cancer remains one of the most formidable challenges in modern medicine, affecting millions of lives globally. Despite advances in early detection, treatment, and supportive care, many forms of cancer remain resistant to conventional therapies, necessitating continuous research into novel approaches. The emergence of a new cancer medication can dramatically alter the treatment landscape, offering fresh hope to patients who have exhausted existing options. In recent years, innovative cancer drugs have targeted tumor biology with greater precision, leveraging mechanisms such as immunotherapy, targeted therapy, and personalized medicine. As researchers push the boundaries of medical science, the development of a new cancer drug has the potential to redefine treatment protocols, improve survival rates, and enhance the quality of life for patients battling this disease. The rapid evolution of oncology treatments underscores the importance of understanding how new cancer drugs work, their mechanisms of action, and their impact on patient outcomes. This article explores the latest breakthroughs in cancer treatment, delves into the science behind emerging medications, and assesses their potential in reshaping the future of cancer care. By examining the clinical research, real-world applications, and regulatory considerations, we provide a comprehensive analysis of how these advancements can influence both current and future cancer therapies.

Best Leukemia Meds: Understanding Treatment Options and Their Effectiveness

Leukemia is a complex and multifaceted malignancy that affects blood-forming tissues, primarily the bone marrow and lymphatic system. It encompasses a variety of subtypes, each with distinct pathological mechanisms and treatment approaches. Over the years, advancements in pharmacology have significantly improved survival rates and quality of life for leukemia patients. The development of targeted leukemia drugs and innovative treatment strategies has revolutionized the management of the disease. This article explores the best leukemia meds available today, analyzing their effectiveness, mechanisms of action, and potential side effects to provide a comprehensive resource for patients, caregivers, and healthcare professionals.

Latest Cancer Treatment Breakthroughs: Advancements in Pharmacological Therapies for Better Outcomes

Cancer remains one of the most pressing health challenges globally, with millions of lives affected each year. However, the landscape of cancer treatment is continuously evolving, with groundbreaking pharmacological advancements offering new hope. The latest cancer treatment options focus on precision medicine, immunotherapy, and targeted therapies that enhance patient survival and quality of life. With recent cancer treatment breakthroughs, researchers and clinicians are increasingly optimistic about improving patient outcomes and moving closer to a cure. This article explores the newest cancer treatment advancements, including innovative drug therapies, novel treatment mechanisms, and emerging trends in oncological pharmacology.

Does Exercise Lower Cholesterol? The Science Behind Physical Activity and Heart Health

Cholesterol plays a crucial role in various physiological processes, but elevated levels, particularly of low-density lipoprotein (LDL) cholesterol, are a major risk factor for cardiovascular disease. The link between physical activity and cholesterol reduction has been extensively studied, raising the question: Does exercise lower cholesterol? Research suggests that engaging in regular physical activity can contribute significantly to improving lipid profiles, reducing cardiovascular risk, and promoting overall metabolic health. The mechanisms through which exercise impacts cholesterol levels are complex, involving enhanced lipid metabolism, increased high-density lipoprotein (HDL) production, and improved arterial function. In this article, we will examine the scientific evidence on whether exercise can lower cholesterol, explore the physiological processes involved, and discuss the best exercise strategies for optimizing cholesterol levels.

Can You Reverse Coronary Heart Disease? Understanding Risks, Treatments, and Lifestyle Interventions

Coronary heart disease (CHD) remains one of the leading causes of mortality worldwide, affecting millions of individuals each year. As the primary driver of heart attacks and other cardiovascular complications, CHD has garnered significant attention from medical professionals and researchers alike. A common question many people ask is: Can you reverse coronary heart disease? This inquiry stems from a growing interest in alternative and lifestyle-based approaches to cardiovascular health. While conventional medicine offers various treatments, emerging research suggests that lifestyle interventions, medical therapies, and dietary adjustments may play a role in reversing certain aspects of CHD. Understanding the mechanisms, risks, and available interventions can help individuals make informed decisions about their heart health.

Related Articles

Popular Categories

spot_imgspot_img